194 related articles for article (PubMed ID: 16009909)
1. Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease.
Mehta KM; Yin M; Resendez C; Yaffe K
Neurology; 2005 Jul; 65(1):159-62. PubMed ID: 16009909
[TBL] [Abstract][Full Text] [Related]
2. Race/ethnic differences in AD survival in US Alzheimer's Disease Centers.
Mehta KM; Yaffe K; Pérez-Stable EJ; Stewart A; Barnes D; Kurland BF; Miller BL
Neurology; 2008 Apr; 70(14):1163-70. PubMed ID: 18003939
[TBL] [Abstract][Full Text] [Related]
3. The Role of Ethnicity in Alzheimer's Disease: Findings From The C-PATH Online Data Repository.
Chen HY; Panegyres PK
J Alzheimers Dis; 2016; 51(2):515-23. PubMed ID: 26890783
[TBL] [Abstract][Full Text] [Related]
4. Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer's Disease Center.
Filshtein TJ; Dugger BN; Jin LW; Olichney JM; Farias ST; Carvajal-Carmona L; Lott P; Mungas D; Reed B; Beckett LA; DeCarli C
J Alzheimers Dis; 2019; 68(1):145-158. PubMed ID: 30775996
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological treatment of Alzheimer's disease: effect of race and demographic variables.
Hernandez S; McClendon MJ; Zhou XH; Sachs M; Lerner AJ
J Alzheimers Dis; 2010; 19(2):665-72. PubMed ID: 20110610
[TBL] [Abstract][Full Text] [Related]
6. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries.
Thorpe CT; Fowler NR; Harrigan K; Zhao X; Kang Y; Hanlon JT; Gellad WF; Schleiden LJ; Thorpe JM
J Am Geriatr Soc; 2016 Sep; 64(9):1806-14. PubMed ID: 27549029
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of cholinesterase inhibitors in Alzheimer's disease.
Håkansson L
Acta Neurol Scand Suppl; 1993; 149():7-9. PubMed ID: 7907455
[TBL] [Abstract][Full Text] [Related]
9. The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort.
Lee JH; Cheng R; Schupf N; Manly J; Lantigua R; Stern Y; Rogaeva E; Wakutani Y; Farrer L; St George-Hyslop P; Mayeux R
Arch Neurol; 2007 Apr; 64(4):501-6. PubMed ID: 17420311
[TBL] [Abstract][Full Text] [Related]
10. Associations of Race-Ethnicity and History of Traumatic Brain Injury With Age at Onset of Alzheimer's Disease.
Bailey KC; Burmaster SA; Schaffert J; LoBue C; Vela D; Rossetti H; Cullum CM
J Neuropsychiatry Clin Neurosci; 2020; 32(3):280-285. PubMed ID: 31619118
[TBL] [Abstract][Full Text] [Related]
11. Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis.
Zhou Q; Zhao F; Lv ZP; Zheng CG; Zheng WD; Sun L; Wang NN; Pang S; de Andrade FM; Fu M; He XH; Hui J; Jiang W; Yang CY; Shi XH; Zhu XQ; Pang GF; Yang YG; Xie HQ; Zhang WD; Hu CY; Yang Z
PLoS One; 2014; 9(1):e87017. PubMed ID: 24498013
[TBL] [Abstract][Full Text] [Related]
12. The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease.
Harwood DG; Kalechstein A; Barker WW; Strauman S; St George-Hyslop P; Iglesias C; Loewenstein D; Duara R
Int J Geriatr Psychiatry; 2010 May; 25(5):511-8. PubMed ID: 19750560
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
14. Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations.
Reitz C; Mayeux R
Biol Psychiatry; 2014 Apr; 75(7):534-41. PubMed ID: 23890735
[TBL] [Abstract][Full Text] [Related]
15. New anti-Alzheimer drugs from biodiversity: the role of the natural acetylcholinesterase inhibitors.
Viegas C; Bolzani Vda S; Barreiro EJ; Fraga CA
Mini Rev Med Chem; 2005 Oct; 5(10):915-26. PubMed ID: 16250834
[TBL] [Abstract][Full Text] [Related]
16. [Acetylcholinesterase inhibitors for treatment of Alzheimer's disease].
Shinagawa S; Shigeta M
Brain Nerve; 2014 May; 66(5):507-16. PubMed ID: 24807367
[TBL] [Abstract][Full Text] [Related]
17. Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis.
Mueller C; Perera G; Hayes RD; Shetty H; Stewart R
Age Ageing; 2018 Jan; 47(1):88-94. PubMed ID: 28655175
[TBL] [Abstract][Full Text] [Related]
18. The APOE-epsilon4 allele and Alzheimer disease among African Americans, Hispanics, and whites.
Méndez HA
JAMA; 1998 Nov; 280(19):1663. PubMed ID: 9831995
[No Abstract] [Full Text] [Related]
19. Apolipoprotein-E epsilon 4 allele frequency and conferred risk for Cuban Americans with Alzheimer's disease.
Sevush S; Peruyera G; Crawford F; Mullan M
Am J Geriatr Psychiatry; 2000; 8(3):254-6. PubMed ID: 10910426
[TBL] [Abstract][Full Text] [Related]
20. Brain acetylcholinesterase activity in Alzheimer disease measured by positron emission tomography.
Shinotoh H; Namba H; Fukushi K; Nagatsuka S; Tanaka N; Aotsuka A; Tanada S; Irie T
Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S114-8. PubMed ID: 10850739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
